Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 7/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | PCNA | P12004 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
| ▸ | THRA | P10827 | 5/20 | 0.37 |
| ▸ | THRB | P10828 | 5/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20746782 | 0.81 | LCK (0.50) | FFAR1KEAP1THRATHRB | |
| SCHEMBL11979660 | 0.81 | ALOX5 (0.39) | ALOX5 | |
| SCHEMBL13266120 | 0.79 | CYP4F2 (0.50) | ALOX5 | |
| SCHEMBL1270234 | 0.77 | PCNA (0.57) | FFAR1KEAP1NPSR1PCNARXRA | |
| SCHEMBL14626789 | 0.77 | ERCC1 (0.54) | — | |
| SCHEMBL28523089 | 0.76 | NPSR1 (0.46) | FFAR1KEAP1NPSR1PCNAFFAR4 | |
| SCHEMBL31433006 | 0.74 | PPARA (0.55) | FFAR1FFAR4ALOX5 | |
| SCHEMBL12672401 | 0.74 | GAA (0.47) | NPSR1 | |
| SCHEMBL11978546 | 0.74 | GAA (0.60) | NPSR1 | |
| SCHEMBL5670212 | 0.73 | KEAP1 (0.64) | FFAR1KEAP1NPSR1PCNAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7786222-B2 | Polyamide oligomers and their use | EMS-CHEMIE AG (CH) | 2010-08-31 | — | — | US | disclosed |
| US-20090131674-A1 | POLYMIDE OLIGOMERS AND THEIR USE | EMS-CHEMIE AG (CH) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131674-A1 | POLYMIDE OLIGOMERS AND THEIR USE | PUF60, PARG, PARN | FFAR1 3307/4885KEAP1 3894/4885NPSR1 1814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.